About this trial
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF.
The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Eligibility criteria
Qualifiers
Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative
For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)
Be willing and able to adhere to the study protocol requirements
Age ≥ 12 years at time of enrollment
Disqualifiers
History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject
History of transplant
Pregnancy reported by participant at time of consent or at any point during active study participation
Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias
Trial design
Treatments tested in this trial
- observational study
Treatment groups
Sponsors and collaborators
Jaeb Center for Health Research
Lead sponsor
Cystic Fibrosis Foundation
Collaborator